QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. QLT is focused on developing its synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the Company is publicly traded on NASDAQ Stock Market (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT).

QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. QLT is focused on developing its synthetic retinoid program for...Show all

See All Exits Recent Exits

Phone: 877-764-3131

Fax:

887 Great Northern Way
Suite 250
Vancouver, V5T 4T5
British Columbia, Canada

QLT - Investments & Acquisitions

Show Real Data QLT Investments
See all Recent Investments
Date Company Round Amount Co-investors
2015-06-08InSite VisionAcq - P2P
2007-04-11ForSight Vision2Acquired
2004-03-29Kinetek PharmaceuticalsAcquired
See all 3 investments